Skip to main content
PBM
NASDAQ Life Sciences

Psyence Labs Ltd. Acquires 30.05% Stake in PSYENCE BIOMEDICAL LTD. via $5M Share Exchange

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$4
Mkt Cap
$4.038M
52W Low
$1.92
52W High
$74.938
52W Position info
108% above low
Off High info
95% below high
Rel. Volume
Market data snapshot near publication time

PBM has more than doubled off its 52-week low of $1.92.

Summary

Psyence Labs Ltd. has become a major shareholder in PSYENCE BIOMEDICAL LTD., acquiring over 30% of the company through a $5 million share exchange as a result of a pre-existing agreement.


Key Events · Ownership and Investor Activity · PBM

  • Significant Stake Acquired

    Psyence Labs Ltd. acquired 1,146,159 common shares, representing 30.05% of PSYENCE BIOMEDICAL LTD.'s outstanding shares.

  • $5 Million Share Exchange

    The acquisition was a share-for-share exchange valued at $5,000,000, where Psyence Labs Ltd. issued its own ordinary shares to PSYENCE BIOMEDICAL LTD. in consideration.

  • Exercise of Put Option

    This transaction resulted from the exercise of an irrevocable put option granted under a Share Put Option and Amendment Agreement dated July 3, 2025, and previously disclosed on February 13, 2026.


Analysis · PBM · Life Sciences

Psyence Labs Ltd. has acquired a 30.05% ownership stake in PSYENCE BIOMEDICAL LTD. through a share-for-share exchange valued at $5 million. This transaction, which occurred on February 25, 2026, resulted from the exercise of a previously disclosed put option. The acquisition of such a significant stake by a strategic entity is a major capital event for the company, especially given its small market capitalization, and represents a substantial change in its ownership structure.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PBM was trading at $4.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4M. The 52-week trading range was $1.92 to $74.94. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PBM - Latest Insights

PBM
Oct 21, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.09
Real-time Price: $2.83 info
Change: -$1.26 (-31%) info
Market Cap: $10.795M info
PBM
Oct 15, 2026, 9:03 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $2.83 info
Change: -$1.17 (-29%) info
Market Cap: $10.795M info
PBM
Oct 05, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $2.83 info
Change: -$2.52 (-47%) info
Market Cap: $10.795M info
PBM
Sep 28, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.86
Real-time Price: $2.83 info
Change: -$3.03 (-52%) info
Market Cap: $10.795M info
PBM
Sep 23, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.42
Real-time Price: $2.83 info
Change: -$3.59 (-56%) info
Market Cap: $10.795M info